사이프러스 에센셜 오일의 흡입이 전임상 실험동물의 손상된 학습능력과 기억력에 미치는 영향 = Cypress Essential Oil Improves Scopolamine-induced Learning and Memory Deficit in C57BL/6 mice

다국어 초록 (Multilingual Abstract)

Objectives : Increasing evidence supports the biological and pharmacological activities of essential oils on the central nervous system such as pain, anxiety, attention, arousal, relaxation, sedation and learning and memory. The purpose of present work is to investigate the protective effect and molecular mechanism of cypress essential oil (CEO) against scopolamine (SCO)-induced cognitive impairments in C57BL/6 mice.
Methods : A series of behavior tests such as Morris water maze, passive avoidance, and fear conditioning tests were conducted to monitor learning and memory functions. Immunoblotting and RT-PCR were also performed in the hippocampal tissue to determine the underlying mechanism of CEO.
Results : SCO induced cognitive impairments as assessed by decreased step-through latency in passive avoidance test, relatively low freezing time in fear conditioning test, and increased time spent to find the hidden platform in Morris water maze test. Conversely, CEO inhalation significantly reversed the SCO-induced cognitive impairments in C57BL/6 mice comparable to control levels. To elucidate the molecular mechanisms of memory enhancing effect of CEO we have examined the expression of brain-derived neurotrophic factor (BDNF) in the hippocampus. CEO effectively elevated the protein as well as mRNA expression of BDNF via activation of cAMP response element binding protein (CREB).
Conclusions : Our findings suggest that CEO inhalation effectively restored the SCO-impaired cognitive functions in C56BL/6 mice. This learning and memory enhancing effect of CEO was partly mediated by up-regulation of BDNF via activation of CREB.

참고문헌 (Reference)

1 Rudy JW, "Understanding contextual fear conditioning : insights from a two-process model" 28 : 675-685, 2004

2 Klinkenberg I, "The validity of scopolamine as a pharmacological model for cognitive impairment : a review of animal behavioral studies" 34 : 1307-1350, 2010

3 Hassanzadeh SL, "The chemical composition and antimicrobial activity of the leaf oil of Cupressus lusitanica from Monteverde, Costa Rica" 2 : 19-21, 2010

4 Ali SA, "Protective role of Juniperus phoenicea and Cupressus sempervirens against CCl4" 1 : 123-131, 2010

5 Ibrahim NA, "Phytochemical investigation and hepatoprotective activity of Cupressus sempervirens L. leaves growing in Egypt" 21 : 857-866, 2007

6 Loizzo MR, "Phytochemical analysis and in vitro antiviral activities of the essential oils of seven Lebanon species" 5 : 461-470, 2008

7 Porres-Martínez M, "In vitro neuroprotective potential of the monoterpenes α-pinene and 1, 8-cineole against H2O2-induced oxidative stress in PC12 cells" 71 : 191-199, 2016

8 Kasuya H1, "Expression of BDNF and TH mRNA in the brain following inhaled administration of α-pinene" 29 : 43-47, 2015

9 Karkabounas S, "Effects of Cupressus sempervirens cone extract on lipid parameters in Wistar rats" 17 : 101-103, 2003

10 Orhan G, "Contemporary anticholinesterase pharmaceuticals of natural origin and their synthetic analogues for the treatment of Alzheimer's disease" 4 : 43-51, 2009

11 Rawat P, "Constituents from fruits of Cupressus sempervirens" 81 : 162-166, 2010

12 Zhou W, "Components of lemon essential oil attenuate dementia induced by scopolamine" 12 : 57-64, 2009

13 Binder DK, "Brain-derived neurotrophic factor" 22 : 123-131, 2004

14 Bekinschtein P, "BDNF and memory formation and storage" 14 : 147-156, 2008

15 Ulusal BG, "Anticoagulant effect of Cupressus sempervirens" 21 : 1116-, 2007

16 Zhang H, "Ameliorating effects of essential oil from Acori graminei rhizoma on learning and memory in aged rats and mice" 59 : 301-309, 2007

17 Dobetsberger C, "Actions of essential oils on the central nervous system : An updated review" 26 : 300-316, 2011

18 Preet Anand, "A review on cholinesterase inhibitors for Alzheimer’s disease" 대한약학회 36 (36): 375-399, 2013